Chien‐Hsing Chang
-
- Monoclonal and Polyclonal Antibodies Research 77
- Radiopharmaceutical Chemistry and Applications 46
- Oncology top 1%
- CAR-T cell therapy research 14
- Peptidase Inhibition and Analysis 13
- HER2/EGFR in Cancer Research 12
- Immunology top 5%
- Immune Cell Function and Interaction 11
-
- Lymphoma Diagnosis and Treatment 19
- Genetics top 5%
-
- Glycosylation and Glycoproteins Research 14
- Co-authors
- David M. GoldenbergEdmund A. RossiRobert M. SharkeyWilliam J. McBrideThomas M. CardilloHabibe KaracayHans J. HansenRhona Stein
- Journals
- Proceedings of the National Academy of Sciences (1 paper)Nature Medicine (1 paper)Journal of Clinical Oncology (2 papers)
- Partner nations
- United StatesNetherlandsFrance
In The Last Decade
Chien‐Hsing Chang
107 papers receiving 4.3k citations
Peers
Comparison fields: 5 of 101
- Radiology, Nuclear Medicine and Imaging 2.9k
- Oncology 1.8k
- Immunology 784
- Pathology and Forensic Medicine 469
- Genetics 232
Countries citing papers authored by Chien‐Hsing Chang
This map shows the geographic impact of Chien‐Hsing Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chien‐Hsing Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chien‐Hsing Chang more than expected).
Fields of papers citing papers by Chien‐Hsing Chang
This network shows the impact of papers produced by Chien‐Hsing Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chien‐Hsing Chang. The network helps show where Chien‐Hsing Chang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Chien‐Hsing Chang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 9 | |
| 2 | 2017 | 67 | |
| 3 | 2017 | 24 | |
| 4 | 2017 | 21 | |
| 5 | 2016 | 42 | |
| 6 | 2015 | 130 | |
| 7 | 2014 | 20 | |
| 8 | 2014 | 29 | |
| 9 | 2013 | 88 | |
| 10 | 2012 | 44 | |
| 11 | 2012 | 11 | |
| 12 | 2010 | 39 | |
| 13 | 2010 | 43 | |
| 14 | 2010 | 16 | |
| 15 | 2009 | 57 | |
| 16 | 2008 | 60 | |
| 17 | 2008 | 53 | |
| 18 | 2008 | 49 | |
| 19 | A modular method to prepare novel tetrameric cytokines, IFN, G-CSF, and EPO, with improved pharmacokinetics by the Dock-and-Lock (DNL) platform technology | 2008 | 2 |
| 20 | Construction, characterization, and mammalian expression of an immunotoxin consisting of ranpirnase (Rap) fused to a humanized anti-EGP-1 antibody, hRS7, as a potential therapeutic for prostate cancer | 2005 | 2 |
About Chien‐Hsing Chang
Chien‐Hsing Chang is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Immunology, having authored 108 papers that have together received 4.4k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (77 papers), Radiopharmaceutical Chemistry and Applications (46 papers), Lymphoma Diagnosis and Treatment (19 papers), Glycosylation and Glycoproteins Research (14 papers), CAR-T cell therapy research (14 papers), Peptidase Inhibition and Analysis (13 papers), HER2/EGFR in Cancer Research (12 papers) and Immune Cell Function and Interaction (11 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (2.9k citations), Oncology (1.8k citations) and Immunology (784 citations). Chien‐Hsing Chang has collaborated with scholars based in United States, Netherlands and France. Frequent co-authors include David M. Goldenberg, Edmund A. Rossi, Robert M. Sharkey, William J. McBride, Thomas M. Cardillo, Habibe Karacay, Hans J. Hansen, Rhona Stein, Serengulam V. Govindan and Christopher D'Souza. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.